This inventor holds 6 USPTO granted patents. Top assignees: Mitsubishi Kasei Corporation, Mitsubishi Chemical Industries Limited. Active years: 1987-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ami, JP (1987 - 1992)
- Ibaraki, JP (1991 - 1992)
Company Filing History:

Years Active: 1987-1992
Title: Hiroyoshi Nishi: Innovator in Pharmaceutical Chemistry
Introduction
Hiroyoshi Nishi is a prominent inventor based in Ami, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 6 patents. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Nishi's latest patents include the development of 4-imidazoline derivatives. These compounds are represented by specific formulas where R groups denote various alkyl and alkenyl structures. Additionally, he has created a lipid-peroxide formation inhibiting composition, which serves as a preventive and therapeutic medicine for ischemic diseases, including brain and heart diseases. His novel pyrazolone derivatives exhibit inhibitory activity and are accompanied by pharmaceutically acceptable salts.
Career Highlights
Throughout his career, Hiroyoshi Nishi has worked with notable companies such as Mitsubishi Kasei Corporation and Mitsubishi Chemical Industries Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Nishi has collaborated with esteemed colleagues, including Yasuhiro Morinaka and Toshiaki Watanabe. These partnerships have fostered a collaborative environment that enhances the research and development of new compounds.
Conclusion
Hiroyoshi Nishi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative work continues to pave the way for advancements in therapeutic medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile